10-Q: Trulieve Narrows Q3 Loss, Boosts Cash Amid Tax Dispute

Trulieve Cannabis Corp. reported a significantly reduced net loss and increased cash reserves in its third quarter, driven by expense control and adult-use sales, despite facing a substantial IRS tax dispute.

Summary

• Net loss for the three months ended September 30, 2025, significantly improved to $(28.784) million from $(61.856) million in the prior year.
• Net loss for the nine months ended September 30, 2025, improved to $(78.654) million from $(99.015) million in the prior year.
• Revenue for the three months ended September 30, 2025, increased by 1% to $288.187 million, primarily due to new store openings, adult-use sales in Ohio, and wholesale growth.
• Revenue for the nine months ended September 30, 2025, increased by 0.3% to $888.033 million.
• Adjusted EBITDA for the three months ended September 30, 2025, rose by 6.9% to $102.7 million, and for the nine months, it increased by 4.4% to $322.5 million, reflecting improved expense control.
• Cash and cash equivalents increased to $449.198 million as of September 30, 2025, from $238.803 million at December 31, 2024.
• Uncertain tax position liabilities increased to $616.315 million as of September 30, 2025, from $445.221 million at December 31, 2024.
• The company issued a notice to redeem all $368.0 million of its outstanding 8% 2026 Notes by December 5, 2025.

Sentiment

Score: 6

Explanation: The company demonstrated significant improvements in net loss and Adjusted EBITDA, alongside a strong increase in cash reserves and proactive debt management. However, modest revenue growth, a substantial increase in uncertain tax liabilities, and a proposed $38.1 million IRS penalty introduce considerable uncertainty and temper the overall positive financial performance.

Positives

• Net loss significantly improved by 61% for the three months ended September 30, 2025, and by 21% for the nine months ended September 30, 2025, compared to the prior year periods.
• Adjusted EBITDA increased by 6.9% to $102.7 million for the quarter and by 4.4% to $322.5 million for the nine months, indicating improved operational efficiency and expense control.
• Cash and cash equivalents more than doubled to $449.198 million as of September 30, 2025, from $238.803 million at December 31, 2024.
• Net cash provided by investing activities improved substantially, moving from a $183.4 million use in the nine months ended September 30, 2024, to a $19.4 million provision in the same period of 2025.
• Selling, general, and administrative expenses decreased by 33% for the quarter and 10% for the nine months, largely due to lower campaign and political contributions.
• The company is proactively managing its debt by issuing a notice to redeem $368.0 million of its 8% 2026 Notes by December 5, 2025.
• Expansion into adult-use markets, such as Ohio, contributed to revenue growth.

Negatives

• Revenue growth was modest, increasing by only 1% for the three months and 0.3% for the nine months ended September 30, 2025, partially offset by price compression.
• Gross profit decreased by 2% to $169.9 million for the three months ended September 30, 2025, and gross margin percentage declined from 61.0% to 58.9% year-over-year for the quarter.
• Net cash provided by operating activities decreased by $27.2 million for the nine months ended September 30, 2025, compared to the prior year.
• Uncertain tax position liabilities increased substantially to $616.315 million as of September 30, 2025, from $445.221 million at December 31, 2024.
• The IRS issued Revenue Agent Reports proposing assessment of taxes, interest, and approximately $38.1 million in penalties for some subsidiaries, which the company plans to contest vigorously.
• A new liability of $6.5 million was recorded due to a tenant defaulting on a cultivation lease for which the company was secondarily liable.

Risks

• The illegality of cannabis under U.S. federal law, which preempts state laws and could lead to asset forfeiture or inability to execute business plans.
• Uncertainty regarding the regulation of cannabis in the U.S., including potential future FDA regulations or reclassification of cannabis.
• The company faces a higher risk of IRS audit and unfavorable tax treatment for cannabis businesses under IRC Section 280E, which disallows ordinary business deductions.
• The IRS has proposed assessments of taxes, interest, and approximately $38.1 million in penalties for some subsidiaries, which the company is vigorously contesting.
• Intense competition in the cannabis industry from single-state, regional, and multi-state operators, as well as the illicit market and intoxicating hemp products.
• Risks related to significant indebtedness, although the company is redeeming some notes.
• Restricted access to banking and other financial services by cannabis businesses.
• Risks related to maintaining cash deposits in excess of federally insured limits due to federal illegality.
• The lack of bankruptcy protections for cannabis businesses.
• Risks related to ineffective internal controls over financial reporting or material weaknesses.
• The company's assets, including cash and cash equivalents, could be subject to civil asset forfeiture.

Future Outlook

The company expects to continue generating cash from operations and believes existing cash balances will be sufficient to meet anticipated cash requirements for at least the next 12 months. Any additional future requirements may be funded through ongoing operations, debt, or equity financings. The company is actively monitoring tariff developments but does not expect them to have a material impact on its business, cost structure, or supply chain. The company plans to continue investments in customer experience, product innovation, scaled production, marketing and branding, and distribution network expansion.

Management Comments

• "The increase [in Adjusted EBITDA] primarily resulted from improved expense control in our core business."
• "We believe the proposed penalties [from the IRS] are without merit and will contest them vigorously."
• "We believe our existing cash balances will be sufficient to meet our anticipated cash requirements from the date of this Quarterly Report on Form 10-Q through at least the next 12 months."

Industry Context

Trulieve operates as a vertically integrated cannabis company in highly regulated U.S. state markets, utilizing a regional hub structure anchored in Florida, Pennsylvania, and Arizona. The company is expanding its adult-use cannabis programs, notably in Ohio, and is focused on product innovation (e.g., THC beverages) and customer experience to compete in an increasingly competitive landscape. The industry faces significant challenges due to federal illegality, which impacts banking, taxation (IRC Section 280E), and asset forfeiture risks, creating a complex operating environment.

Comparison to Industry Standards

• The filing does not provide specific comparable company, project, or industry benchmark data to assess results against global standards.

Legal Proceedings

• The IRS issued Revenue Agent Reports (RARs) in September 2025, proposing assessment of taxes, interest, and approximately $38.1 million in penalties for some of the company's subsidiaries under audit.
• The company has submitted protests to dispute these proposed liabilities before the IRS Independent Office of Appeals and believes the proposed penalties are without merit.
• The company has taken a position that IRC Section 280E does not preclude it from deducting ordinary and necessary business expenditures on its tax returns, which is a key part of its uncertain tax position liabilities.

Related Party Transactions

• The company rents an asset from an entity directly owned in part by its Chief Executive Officer and Chair of the board of directors, incurring an expense of $0.1 million for the three months and $0.2 million for the nine months ended September 30, 2025.
• The company leases a cultivation facility and corporate office from an entity indirectly owned by its Chief Executive Officer and Chair of the board of directors, a former board member, and another board member. Related right-of-use assets were $481,000 and lease liabilities were $520,000 as of September 30, 2025, with lease expense of $0.1 million for the three months and $0.2 million for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders: Improved profitability metrics (net loss, Adjusted EBITDA) and a stronger cash position are positive, but the significant increase in uncertain tax liabilities and the proposed IRS penalties represent a material financial risk. The debt redemption could be viewed favorably for balance sheet management.
• Creditors: The redemption of $368.0 million in notes reduces future interest obligations and demonstrates financial strength, while the company remains in compliance with all operating and financial covenants.
• Customers: Continued focus on customer experience, product innovation (e.g., new beverage launches), and expansion of the distribution network aim to enhance customer satisfaction and access to products.
• Employees: No direct impact on employees was explicitly detailed, but operational efficiency and growth could imply job stability and opportunities.
• Regulatory Authorities: The ongoing dispute with the IRS regarding tax positions under IRC Section 280E highlights the complex regulatory environment for cannabis businesses.

Next Steps

• Contest the proposed $38.1 million in penalties and other assessments from the IRS.
• Complete the redemption of $368.0 million of 8% 2026 Notes by December 5, 2025.
• Continue evaluating the impact of new accounting pronouncements (ASU 2025-05 and ASU 2025-06).
• Continue investments in customer experience, product innovation, scaled production, marketing and branding, and distribution network expansion.

Key Dates

Recommendation

While Trulieve demonstrated significant improvements in net loss and Adjusted EBITDA, along with a robust increase in cash and proactive debt management through note redemption, the modest revenue growth and the substantial, ongoing dispute with the IRS over $616.3 million in uncertain tax liabilities, including a proposed $38.1 million in penalties, introduce considerable financial and regulatory uncertainty. The federal illegality of cannabis continues to pose fundamental risks to the business model, making a 'hold' recommendation prudent until there is greater clarity on these significant tax and regulatory challenges.

Keywords

cannabis, Trulieve, TCNNF, marijuana, SEC filing, 10-Q, financial results, Q3 2025, cannabis industry, multi-state operator, adjusted EBITDA, net loss, revenue, tax liabilities, IRS audit, debt redemption, Florida cannabis, Ohio adult-use, wholesale cannabis, retail cannabis